Splitero reports on strategies for managing post-holiday debt, comparing home equity and credit card options to reduce ...

JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) is a large-scale, income-focused ETF with a market capitalization of $31.11 ...

IonQ is a key quantum player with strong cash and M&A activity, but faces tech scalability issues, dilution, and tough ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

Key Points Initiated position: 528,376 shares bought, estimated at $15.32 million based on the average price in Q3 2025 ...

Taking a closer look at delta as it applies to options trading as the Delta variant of Covid-19 pandemic ensues ...

Manchester Pride’s CEO Mark Fletcher has, in the past, faced backlash over his salary. In 2021, having 'cut ties' with two ...

In the preceding three months, 5 analysts have released ratings for Kiniksa Pharmaceuticals (NASDAQ: KNSA ), presenting a wide array of perspectives from bullish to bearish. The table below provides a ...

Public health leaders “have to figure out how to reach” those who are open to persuasion on vaccines and more, says former ...

Of Harvard’s schools, HSPH has been by far the most reliant on government grants—and so was the hardest hit by the Trump ...

Midwest IPO subscription began on October 15, with a price band of ₹1,014 to ₹1,065. The firm aims to raise ₹451 crore and ...